Welter Stefan, Jacobs Jan, Krbek Thomas, Krebs Bettina, Stamatis Georgios
Department of Thoracic Surgery, Ruhrlandklinik, Essen, Germany.
Ann Thorac Surg. 2007 Jul;84(1):203-10. doi: 10.1016/j.athoracsur.2007.03.028.
The purpose of this study was to evaluate the outcome of patients undergoing repeated resection of pulmonary metastases from colorectal cancer and specify factors promising long-term survival.
From January 1993 to December 2003, 175 patients were diagnosed and resected for pulmonary metastases of colorectal cancer. Follow-up information was collected for 169 patients, and 33 (19.5%) had had recurrent metastasectomies up to three times. Their follow-up information was updated in August 2006. The first repeated resection was performed for up to six bilateral metastases, the second and third metastasectomies were each unilateral and for a single metastasis only. Lymph node involvement was present in 5 patients who underwent repeat resections.
The overall (n = 169) median survival was 47.2 months after the first metastasectomy. The 33 patients with repeated resections had a median survival of 72.6 months, with survival of 53.8% at 5 years and 20.6% at 10 years. After reoperation, age, sex, primary tumor stage, preoperative carcinoembryonic antigen, disease-free interval, prior resection of liver metastases, and lymph node involvement were not found to be of prognostic importance. The only factor that significantly influenced survival was the number of metastases (hazard risk, 1.299). Perioperative mortality even for repeated resections was 0%.
Repeated resection of pulmonary metastases secondary to colorectal cancer is safe and can provide long-term survival for highly selected patients.
本研究旨在评估接受结直肠癌肺转移灶重复切除患者的预后,并明确有望实现长期生存的因素。
1993年1月至2003年12月,175例患者被诊断为结直肠癌肺转移并接受了切除手术。收集了169例患者的随访信息,其中33例(19.5%)接受了多达三次的复发性转移灶切除术。他们的随访信息于2006年8月更新。首次重复切除针对多达六个双侧转移灶,第二次和第三次转移灶切除术均为单侧且仅针对单个转移灶。接受重复切除的5例患者存在淋巴结受累情况。
首次转移灶切除术后,总体(n = 169)中位生存期为47.2个月。33例接受重复切除的患者中位生存期为72.6个月,5年生存率为53.8%,10年生存率为20.6%。再次手术后,年龄、性别、原发肿瘤分期、术前癌胚抗原、无病间期、既往肝转移灶切除术以及淋巴结受累情况均未发现具有预后意义。唯一显著影响生存的因素是转移灶数量(风险比,1.299)。即使是重复切除手术,围手术期死亡率也为0%。
结直肠癌继发肺转移灶的重复切除是安全的,对于经过严格筛选的患者可提供长期生存。